The Communicable Diseases Agency (CDA) has announced that public health measures were activated for two Singapore residents who had previously been onboard an overseas cruise vessel (MV Hondius) where an outbreak of hantavirus was reported.
Both individuals were identified as a precaution, isolated, and monitored by the authorities. They have since tested negative for hantavirus. There is no evidence of community transmission in Singapore, and the overall risk to the public remains low.
More information on hantavirus and the public health measures activated can be found in CDA’s press release here.
Important facts about hantavirus
- Hantavirus infections are rare.
- Transmission is typically through contact with rodents or exposure to environments contaminated by rodent urine or droppings.
- Only the Andes strain, found mainly in South America, has been associated with limited human‑to‑human transmission.
Signs and symptoms
Symptoms may include:
- Fever
- Body aches
- Fatigue
- Headache
- Nausea, vomiting, or diarrhoea
- Shortness of breath or breathing difficulties (in more severe cases)
When to see a doctor
Please seek medical attention promptly if you have symptoms and have had relevant exposure, including within 45 days prior to symptom onset:
- Travel on or visit to a vessel, aircraft, or other conveyance with a confirmed or probable hantavirus (Andes virus) case (including MV Hondius); OR
- Exposure to a suspected or confirmed hantavirus (Andes virus) case
Fullerton Health Singapore’s support
Fullerton Health Singapore and our network of primary care and specialist clinics islandwide continue to operate as usual. Clients who require medical consultation or advice may:
- Use the Fullerton Health Concierge app to book appointments and access services. The app is available for download on the Apple app store (iPhone) and Google Play Store (Android).
- Locate a nearby Fullerton Health clinic
We will continue to monitor updates from the Ministry of Health (MOH) and CDA closely and keep you informed should there be any changes to the current risk assessment.
Dr. Marcus Lee
Medical Director
Clinical Quality & Governance,
Fullerton Health, Singapore